Digestive remedies in Switzerland is expected to increase marginally over the forecast period. However, sales of digestive remedies are very likely to be further impacted by the maturity of the category.
Other potential threats to growth include the increasing adoption of healthier lifestyles, with greater consumer focus on illness prevention. Swiss consumers are expected to continue seeking to improve their eating habits and to adopt healthier diets, which can help to avoid certain digestive problems.
Digestive remedies is expected to remain a fragmented category over the forecast period, with only Janssen-Cilag AG maintaining a higher value share than all its competitors. Janssen-Cilag’s first position in digestive remedies can be attributed to its best-selling brand Imodium.
Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).
This report comes in PDF with additional info in Excel included.
Understand the latest market trends and future growth opportunities for the Digestive Remedies industry in Switzerland with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.
Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.
If you're in the Digestive Remedies industry in Switzerland, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.
Includes remedies designed and marketed to treat gastrointestinal problems.See All of Our Definitions
This report originates from Passport, our Digestive Remedies research and analysis database.
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!